In his 30 years as teacher and administrator, Jason Purcell felt the weight of responsibility that often fell on his ...
"If I can't advocate for people who need it, then who else is going to do it?" ...
First patients dosed in DAYBreak™ registrational program for bexobrutideg in relapsed/refractory CLLPresented Phase 1 results at ASH 2025 that ...
Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody and Moditope active immunotherapies to treat cancer, today announces a business ...
The financial trajectory of the exosome therapy market is decoupling from the broader, slower-growing regenerative medicine ...
The proposal is raising questions about focus, safety and enforcement.
Status: The House courts committee approved this bill by an 8-5 vote on Jan. 21, and it now moves to the full House for ...
Bria-IMT demonstrates a median overall survival of 15.6 months, surpassing historical data for heavily pretreated metastatic ...
As a young teenager, Javid and his brother were caught stealing from slot machines, arrested and held in a cell. His future hung in the balance. How did he get from there to the top of UK politics?
The FDA granted fast track designation (FTD) to IBI3003, a first-in-class trispecific antibody, for the treatment of patients ...
Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed improvements in cutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results